Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 8, 2026

Measuring Psoriasis Severity at Home
02:28

Measuring Psoriasis Severity at Home

Published on: March 1, 2024

European consensus recommendations for nummular eczema: A modified Delphi study.

Mette Deleuran1, Kilian Eyerich2, Marjolein de Bruin-Weller3

  • 1Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.

Journal of the European Academy of Dermatology and Venereology : JEADV
|July 7, 2026
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Dupilumab and Upadacitinib Treatment on Epigenetic and Transcriptomic Alterations in Skin-Homing T Cells of Atopic Dermatitis Patients.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Antigen-restricted Candida albicans Th17 cells link oral-gut immunity and adopt pathogenic features during intestinal inflammation.

Immunity·2026
Same author

Clinical and molecular improvements in pediatric patients with atopic dermatitis treated with dupilumab: an analysis from the TREATKids registry.

The Journal of investigative dermatology·2026
Same author

Addiction in chronic inflammatory skin diseases: A systematic review of prevalence, impact and screening practices.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Author Correction: Atopic dermatitis.

Nature reviews. Disease primers·2026
Same author

Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin).

Dermatology and therapy·2026

Nummular eczema (NE) management now has expert recommendations for diagnosis and treatment. These guidelines address the need for better patient assessment tools and more research into systemic therapies for this chronic skin condition.

Area of Science:

  • Dermatology
  • Clinical Practice Guidelines
  • Inflammatory Skin Diseases

Background:

  • Nummular eczema (NE) is a chronic, pruritic skin disease impacting quality of life.
  • Lack of established clinical guidelines hinders NE diagnosis and management.
  • NE significantly burdens patients with sleep disturbance and psychological distress.

Purpose of the Study:

  • Develop the first expert consensus recommendations for NE.
  • Establish guidelines for NE definition, diagnosis, patient assessment, and treatment.

Main Methods:

  • A Scientific Committee developed 64 statements based on literature review and expertise.
  • 63 international experts evaluated statements using a modified Delphi method.
  • Consensus-driven statements informed practical, evidence-based clinical recommendations.
Keywords:
Janus kinase inhibitorscalcineurin inhibitorsclinical recommendationsconsensuscyclosporineglucocorticoidsmethotrexatemodified Delphimonoclonal antibodiesnummular eczema

Related Experiment Videos

Last Updated: Jul 8, 2026

Measuring Psoriasis Severity at Home
02:28

Measuring Psoriasis Severity at Home

Published on: March 1, 2024

Main Results:

  • 49 of 64 statements (76.6%) achieved consensus.
  • Recommendations emphasize clinical diagnosis and individualized, long-term management.
  • Endorsed treatments include topical corticosteroids, calcineurin inhibitors, JAK inhibitors, phototherapy, and systemic agents for refractory cases.

Conclusions:

  • First expert consensus provides a framework for NE diagnosis and management.
  • Offers practical guidance to improve care for NE patients.
  • Identifies critical gaps: need for validated assessment tools and trials for systemic therapies.